We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TSNDF market cap is 545.44M. The company's latest EPS is USD -0.2724 and P/E is -7.78.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 90.35M | 147.83M | 210.42M | 250.51M | 317.33M |
Operating Income | -134.94M | 20.5M | 31.93M | -349.7M | -14.21M |
Net Income | -215.79M | -139.2M | 3.11M | -329.91M | -95.55M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 460.77M | 427.24M | 581.93M | 701.59M | 666.52M |
Total Liabilities | 385.44M | 440.56M | 352.98M | 380.42M | 425.78M |
Total Equity | 75.33M | -13.32M | 228.95M | 321.17M | 240.74M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -47.91M | -36.97M | -31.82M | -26.12M | 27.47M |
Investing | -138.22M | -45.89M | -132.42M | -27.58M | -16.22M |
Financing | 176.98M | 133.41M | 182.2M | 3.72M | -12.5M |
Market Cap | 545.44M |
Price to Earnings Ratio | -7.78 |
Price to Sales Ratio | 2.34 |
Price to Cash Ratio | 33.44 |
Price to Book Ratio | 3.09 |
Dividend Yield | - |
Shares Outstanding | 350.76M |
Average Volume (1 week) | 310.73k |
Average Volume (1 Month) | 412.49k |
52 Week Change | -11.65% |
52 Week High | 2.45 |
52 Week Low | 1.29 |
Spread (Intraday) | 0.01 (0.64%) |
Company Name | Terrascend Corporation (QX) |
Address |
3610 mavis road mississauga, ontario L5C 1W2 |
Website | https://www.terrascend.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions